The pet therapeutic diet market is expected to reach USD 61.38 billion by 2035, growing at a CAGR of 7.92%. Increasing pet diseases, vet support, and demand for customized nutrition are driving growth.
The pet therapeutic diet market size accounted for USD 28.64 billion in 2025 and is predicted to increase from USD 30.91 billion in 2026 to approximately USD 61.38 billion by 2035, expanding at a CAGR of 7.92% from 2026 to 2035. Growing demand for pet therapeutic diets because of increasing chronic diseases, preventive health focus, progressive vet support, and strong veterinary effect.
Therapeutic diets are specially formulated pet foods designed to be the only food given to pets with particular health challenges. They work alongside or as substitutes to medications, helping to treat or prevent diseases in animals. Developed over many years by veterinarians, animal nutritionists, and researchers, these diets have been validated via research and feeding trials to support, manage, or cure specific conditions. Each diet targets one or more precise health problems in dogs or cats. Furthermore, these diets support lowering plaque and tartar buildup on the teeth.
Wearable devices and smart tech are transforming how we monitor pet health. These tools track vital signs, activity, and behaviour, providing real-time insights into a pet’s wellbeing. Some advanced systems can even anticipate potential health challenges early, allowing proactive interventions. Pet owners are more frequently looking for customized nutrition plans suited to their pets’ particular requirements. Companies recently offer tailored meal plans based on factors like breed, age, weight, activity level, and health conditions.

| Animal | Percentages |
| Dogs | 49% |
| Cats | 51% |
In 2025, North America dominated the pet therapeutic diet market with a share of 38% in 2025, as increasing obesity, diabetes, and kidney diseases in pets demand long-term, particular nutritional care. Sophisticated distribution channels, involving online, are driving access to intended diets, which contributes to the growth of the market.
Asia Pacific held 22% share of the market. expected to experience the fastest growth with 9.10% CAGR during the forecast period, as increasing urban populations in nations like China and India are indicating an increase in the number of people owning pets, often living in apartments. Rising vet visits in countries such as Japan and Australia, along with advanced diagnostic services, drive recommendations for therapeutic food.
The top five organizations in this group dominate the pet therapeutic diet market. Meanwhile, Nestlé Purina PetCare offers a broad range of veterinary-exclusive formulas, mainly focused on healthcare nutrition. Blue Buffalo offers natural therapeutic diets, which have functional advantages. Farmina Pet Foods offers a variety of pet food products intended with a balance of natural ingredients and modern technology. Virbac is an animal health organization offering veterinary-exclusive diets. Mars Petcare is a major leader focusing on breed-driven and scientifically backed therapeutic nutrition.
By Pet Type
By Indication
By Product Type
By Distribution Channel
By Ingredient Type
By Formulation
By Region
Speak with a healthcare analyst about your research, consulting, or platform needs.